{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:10:29Z","timestamp":1778227829699,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11060-026-05512-8","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:28:00Z","timestamp":1774344480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes of stereotactic body radiotherapy for spinal metastases with paraspinal extension"],"prefix":"10.1007","volume":"177","author":[{"given":"D.","family":"Ross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Vuppala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"LeCompte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bydon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kebaish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Theodore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. R.","family":"Kleinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Hun.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lubelski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. J.","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"5512_CR1","doi-asserted-by":"crossref","unstructured":"Brande RVD et al. (2022). Available: Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: a systematic review. J Educ Chang Bone Oncol 35. https:\/\/doi.org\/10.1016\/j.jbo.2022.100446https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2212137422000367","DOI":"10.1016\/j.jbo.2022.100446"},{"issue":"10422","key":"5512_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0140-6736(23)02351-6","volume":"403","author":"GG Hanna","year":"2024","unstructured":"Hanna GG, McDonald F (2024). Available: SBRT for oligoprogressive disease: using the evidence to maximise the benefits. Lancet 403(10422):122\u2013124. https:\/\/doi.org\/10.1016\/S0140-6736(23)02351-6","journal-title":"Lancet"},{"key":"5512_CR3","doi-asserted-by":"crossref","unstructured":"Kinj R et al. (2022). Available: Stereotactic body radiation therapy in patients with Oligometastatic disease: clinical state of the art and perspectives\u201d. Cancers (Basel) 14, (5), pp. 1152. https:\/\/doi.org\/10.3390\/cancers14051152https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8909365\/","DOI":"10.3390\/cancers14051152"},{"key":"5512_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3389\/fonc.2019.00337","volume":"9","author":"KL Zeng","year":"2019","unstructured":"Zeng KL et al. (2019). Available: Stereotactic body radiotherapy (SBRT) for Oligometastatic Spine metastases: an Overview. Front Oncol 9:337. https:\/\/doi.org\/10.3389\/fonc.2019.00337https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6504814\/","journal-title":"Front Oncol"},{"issue":"5","key":"5512_CR5","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.ijrobp.2020.09.019","volume":"108","author":"A Sahgal","year":"2020","unstructured":"Sahgal A et al. (2020). Available: CCTG SC.24\/TROG 17.06: a randomized phase II\/III study Comparing 24Gy in 2 stereotactic body radiotherapy (SBRT) fractions versus 20Gy in 5 conventional Palliative radiotherapy (CRT) fractions for patients with painful spinal metastases. Int J Radiat Oncol Biol Phys 108(5):1397\u20131398. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.09.019https:\/\/pubmed.ncbi.nlm.nih.gov\/33427654\/","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"5512_CR6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(21)00196-0","volume":"22","author":"A Sahgal","year":"2021","unstructured":"Sahgal A et al. (2021). Available: Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2\/3 trial. The Lancet Oncol 22(7):1023\u20131033. https:\/\/doi.org\/10.1016\/S1470-2045(21)00196-0https:\/\/pubmed.ncbi.nlm.nih.gov\/34126044\/","journal-title":"The Lancet Oncol"},{"issue":"2","key":"5512_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.radonc.2018.04.030","volume":"128","author":"T Sprave","year":"2018","unstructured":"Sprave T et al. (2018). Available: Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy. Radiother Oncol 128(2):274\u2013282. https:\/\/doi.org\/10.1016\/j.radonc.2018.04.030https:\/\/pubmed.ncbi.nlm.nih.gov\/29843899\/","journal-title":"Radiother Oncol"},{"key":"5512_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.radonc.2020.01.030","volume":"146","author":"R Singh","year":"2020","unstructured":"Singh R et al. (2020). Available: Single fraction radiosurgery, fractionated radiosurgery, and conventional radiotherapy for spinal oligometastasis (SAFFRON): a systematic review and meta-analysis. Radiother Oncol 146:76\u201389. https:\/\/doi.org\/10.1016\/j.radonc.2020.01.030https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0167814020300621","journal-title":"Radiother Oncol"},{"issue":"1","key":"5512_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijrobp.2020.10.039","volume":"110","author":"J Grimm","year":"2021","unstructured":"Grimm J et al. (2021). Available: High dose per fraction, hypofractionated treatment effects in the clinic (HyTEC): an Overview. Int J Radiat Oncol Biol Phys 110(1):1\u201310. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.10.039https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9447432\/","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"5512_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11060-020-03534-4","volume":"148","author":"RO Kowalchuk","year":"2020","unstructured":"Kowalchuk RO et al. (2020). Available: Stereotactic radiosurgery for the treatment of bulky spine metastases. J Neurooncol 148(2):381\u2013388. https:\/\/doi.org\/10.1007\/s11060-020-03534-4https:\/\/pubmed.ncbi.nlm.nih.gov\/32415643\/","journal-title":"J Neurooncol"},{"issue":"4","key":"5512_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/neuros\/nyaa109","volume":"87","author":"JS Detsky","year":"2020","unstructured":"Detsky JS et al. (2020). Available: Mature imaging-based outcomes supporting local control for complex reirradiation Salvage Spine stereotactic body radiotherapy. Neurosurgery 87(4):816\u2013822. https:\/\/doi.org\/10.1093\/neuros\/nyaa109https:\/\/pubmed.ncbi.nlm.nih.gov\/32374852\/","journal-title":"Neurosurgery"},{"issue":"2","key":"5512_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijrobp.2015.03.029","volume":"93","author":"I Thibault","year":"2015","unstructured":"Thibault I et al. (2015). Available: Salvage stereotactic body radiotherapy (SBRT) following In-field failure of Initial SBRT for spinal metastases. Int J Multiling Radiat Oncol*Biol*Phys 93(2):353\u2013360. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.03.029https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0360301615003508","journal-title":"Int J Multiling Radiat Oncol*Biol*Phys"},{"issue":"5","key":"5512_CR13","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/neuros\/nyaa583","volume":"88","author":"KL Zeng","year":"2021","unstructured":"Zeng KL et al. (2021). Available: Prognostic factors associated with surviving less than 3 months vs greater than 3 years specific to Spine stereotactic body radiotherapy and late adverse events. Neurosurgery 88(5):971\u2013979. https:\/\/doi.org\/10.1093\/neuros\/nyaa583https:\/\/pubmed.ncbi.nlm.nih.gov\/33475723\/","journal-title":"Neurosurgery"},{"issue":"4","key":"5512_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.prro.2023.03.009","volume":"13","author":"L Burgess","year":"2023","unstructured":"Burgess L et al. (2023). Available: Stereotactic body radiation therapy for posterior element-only spinal metastases: a first report on outcomes and Validation of Recommended clinical target volume delineation practice. Pract Radiat Oncol 13(4):321\u2013327. https:\/\/doi.org\/10.1016\/j.prro.2023.03.009https:\/\/pubmed.ncbi.nlm.nih.gov\/36997023\/","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"5512_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/ol.2024.14751","volume":"29","author":"JR Linzey","year":"2025","unstructured":"Linzey JR et al. (2025). Available: Role of epidural disease in local control of spinal metastases treated with stereotactic body radiation therapy. Oncol Lett 29(1):5. https:\/\/doi.org\/10.3892\/ol.2024.14751https:\/\/pubmed.ncbi.nlm.nih.gov\/39492935\/","journal-title":"Oncol Lett"},{"issue":"5","key":"5512_CR16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.ijrobp.2015.03.037","volume":"92","author":"AJ Bishop","year":"2015","unstructured":"Bishop AJ et al. (2015). Available: Outcomes for Spine stereotactic body radiation therapy and an analysis of predictors of local recurrence. Int J Radiat Oncol Biol Phys 92(5):1016\u20131026. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.03.037https:\/\/pubmed.ncbi.nlm.nih.gov\/26025777\/","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5512_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11060-025-05126-6","volume":"175","author":"S Taori","year":"2025","unstructured":"Taori S et al. (2025). Available: Long term outcomes following upfront stereotactic body radiotherapy alone for spinal metastases. J Neurooncol 175(1):243\u2013254. https:\/\/doi.org\/10.1007\/s11060-025-05126-6https:\/\/pubmed.ncbi.nlm.nih.gov\/40522562\/","journal-title":"J Neurooncol"},{"issue":"1","key":"5512_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ijrobp.2011.05.067","volume":"83","author":"SA Koyfman","year":"2012","unstructured":"Koyfman SA et al. (2012). Available: Marginal recurrence requiring salvage radiotherapy after stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys 83(1):297\u2013302. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.05.067https:\/\/pubmed.ncbi.nlm.nih.gov\/21985940\/","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5512_CR19","doi-asserted-by":"crossref","unstructured":"Ong WL et al. (2023). Available: Outcomes specific to spinal metastases with paraspinal disease extension following Spine stereotactic body radiotherapy. Int J Multiling Radiat Oncol*Biol*Phys 117(2, Supplement), pp. e142\u2013e143. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.06.954https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0360301623053889","DOI":"10.1016\/j.ijrobp.2023.06.954"},{"key":"5512_CR20","unstructured":"Ong WL et al. (2025). Available: Outcomes following stereotactic body radiation therapy specific to spinal metastases with paraspinal disease extension: does volume matter? J Neurosurg Spine 1\u20139. https:\/\/doi.org\/10.3171\/2025.6.SPINE25376https:\/\/pubmed.ncbi.nlm.nih.gov\/41202272\/"},{"issue":"1","key":"5512_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijrobp.2016.09.014","volume":"97","author":"KJ Redmond","year":"2017","unstructured":"Redmond KJ et al. (2017). Available: Consensus contouring guidelines for post-Operative stereotactic body radiation therapy (SBRT) for metastatic solid tumor malignancies to the Spine. Int J Radiat Oncol Biol Phys 97(1):64\u201374. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.09.014https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5600487\/","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"5512_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ijrobp.2012.03.009","volume":"83","author":"BW Cox","year":"2012","unstructured":"Cox BW et al. (2012). Available: International Spine radiosurgery consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 83(5):597. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.03.009https:\/\/pubmed.ncbi.nlm.nih.gov\/22608954\/","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5512_CR23","doi-asserted-by":"publisher","first-page":"109966","DOI":"10.1016\/j.radonc.2023.109966","volume":"190","author":"M Guckenberger","year":"2024","unstructured":"Guckenberger M et al. (2024). Available: ESTRO clinical practice guideline: stereotactic body radiotherapy for spine metastases. Radiother Oncol 190:109966. https:\/\/doi.org\/10.1016\/j.radonc.2023.109966https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0167814023898607","journal-title":"Radiother Oncol"},{"issue":"2","key":"5512_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ijrobp.2012.05.007","volume":"85","author":"A Sahgal","year":"2013","unstructured":"Sahgal A et al. (2013). Available: Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. Int J Radiat Oncol Biol Phys 85(2):341\u2013347. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.05.007https:\/\/pubmed.ncbi.nlm.nih.gov\/22713832\/","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"5512_CR25","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2010","unstructured":"Benedict SH et al. (2010). Available: Stereotactic body radiation therapy: the report of AAPM task group 101. Med Phys 37(8):4078\u20134101. https:\/\/doi.org\/10.1118\/1.3438081","journal-title":"Med Phys"},{"key":"5512_CR26","doi-asserted-by":"publisher","first-page":"111304","DOI":"10.1016\/j.radonc.2025.111304","volume":"214","author":"F Alongi","year":"2026","unstructured":"Alongi F et al. (2026). Available: ESTRO-ISRS clinical practice recommendations for re-irradiation of spinal metastases with Stereotactic Body Radiotherapy: Delphi consensus supported by a systematic review and meta-analysis. Radiother Oncol 214:111304. https:\/\/doi.org\/10.1016\/j.radonc.2025.111304:https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0167814025053083","journal-title":"Radiother Oncol"},{"issue":"6","key":"5512_CR27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3171\/2025.4.SPINE241281","volume":"43","author":"NK Vuppala","year":"2025","unstructured":"Vuppala NK et al. (2025). Available: Oncological outcomes and safety after spinal reirradiation with stereotactic body radiotherapy. J Neurosurg Spine 43(6):751\u2013759. https:\/\/doi.org\/10.3171\/2025.4.SPINE241281:https:\/\/pubmed.ncbi.nlm.nih.gov\/40939207\/","journal-title":"J Neurosurg Spine"},{"key":"5512_CR28","doi-asserted-by":"crossref","unstructured":"Thibault I et al. (2015). Available: Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. The Lancet Oncol 16, (16:595). https:\/\/doi.org\/10.1016\/S1470-2045(15)00166-7:https:\/\/pubmed.ncbi.nlm.nih.gov\/26678212\/","DOI":"10.1016\/S1470-2045(15)00166-7"},{"issue":"1","key":"5512_CR29","doi-asserted-by":"publisher","first-page":"101327","DOI":"10.1016\/j.adro.2023.101327","volume":"9","author":"PP Patel","year":"2024","unstructured":"Patel PP et al. (2024). Available: Oncologic and functional outcomes after stereotactic body radiation therapy for high-grade malignant spinal cord compression. Adv Radiat Oncol 9(1):101327. https:\/\/doi.org\/10.1016\/j.adro.2023.101327:https:\/\/pubmed.ncbi.nlm.nih.gov\/38260225\/","journal-title":"Adv Radiat Oncol"},{"key":"5512_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.radonc.2020.06.009","volume":"150","author":"X Chen","year":"2020","unstructured":"Chen X et al. (2020). Available: Normal tissue complication probability of vertebral compression fracture after stereotactic body radiotherapy for de novo spine metastasis. Radiother Oncol 150:142\u2013149. https:\/\/doi.org\/10.1016\/j.radonc.2020.06.009:https:\/\/pubmed.ncbi.nlm.nih.gov\/32540335\/","journal-title":"Radiother Oncol"},{"key":"5512_CR31","doi-asserted-by":"crossref","unstructured":"Shaw E et al. (1993). Available: Radiation therapy oncology group: radiosurgery quality assurance guidelines. Int J Multiling Radiat Oncol*Biol*Phys. https:\/\/doi.org\/10.1016\/0360-3016(93)90548-a:https:\/\/mdanderson.elsevierpure.com\/en\/publications\/radiation-therapy-oncology-group-radiosurgery-quality-assurance-g\/","DOI":"10.1016\/0360-3016(93)90548-A"},{"issue":"1","key":"5512_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11060-020-03691-6","volume":"152","author":"KL Zeng","year":"2021","unstructured":"Zeng KL et al. (2021). Available: \u201cLocal control and patterns of failure for \u201cradioresistant\u201d spinal metastases following stereotactic body radiotherapy compared to a \u201cradiosensitive\u201d reference\u201d. J Neurooncol 152(1):173\u2013182. https:\/\/doi.org\/10.1007\/s11060-020-03691-6","journal-title":"J Neurooncol"},{"issue":"3","key":"5512_CR33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ijrobp.2018.06.047","volume":"102","author":"C Tseng","year":"2018","unstructured":"Tseng C et al. (2018). Available: Imaging-based outcomes for 24 Gy in 2 daily fractions for patients with de novo spinal metastases treated with Spine stereotactic body radiation therapy (SBRT). Int J Radiat Oncol Biol Phys 102(3):499\u2013507. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.06.047:https:\/\/pubmed.ncbi.nlm.nih.gov\/30003994\/","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"5512_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ijrobp.2022.05.043","volume":"114","author":"KL Zeng","year":"2022","unstructured":"Zeng KL et al. (2022). Available: Mature local control and reirradiation rates Comparing Spine stereotactic body radiation therapy with conventional Palliative external beam radiation therapy. Int J Multiling Radiat Oncol*Biol*Phys 114(2):293\u2013300. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.05.043:https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0360301622005508","journal-title":"Int J Multiling Radiat Oncol*Biol*Phys"},{"issue":"5","key":"5512_CR35","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3171\/2015.2.SPINE14618","volume":"23","author":"V Puvanesarajah","year":"2015","unstructured":"Puvanesarajah V et al. (2015). Available: Prognostic factors associated with pain palliation after spine stereotactic body radiation therapy. J Neurosurg Spine 23(5):620\u2013629. https:\/\/doi.org\/10.3171\/2015.2.SPINE14618:https:\/\/pubmed.ncbi.nlm.nih.gov\/26230422\/","journal-title":"J Neurosurg Spine"},{"key":"5512_CR36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.radonc.2022.05.035","volume":"173","author":"X Chen","year":"2022","unstructured":"Chen X et al. (2022). Available: Deviation from consensus contouring guidelines predicts inferior local control after spine stereotactic body radiotherapy. Radiother Oncol 173:215\u2013222. https:\/\/doi.org\/10.1016\/j.radonc.2022.05.035:https:\/\/pubmed.ncbi.nlm.nih.gov\/35667571\/","journal-title":"Radiother Oncol"},{"issue":"2","key":"5512_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ijrobp.2019.10.011","volume":"106","author":"KJ Redmond","year":"2020","unstructured":"Redmond KJ et al. (2020). Available: A phase 2 study of post-Operative stereotactic body radiation therapy (SBRT) for solid tumor Spine metastases. Int J Radiat Oncol Biol Phys 106(2):261\u2013268. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.10.011:https:\/\/pubmed.ncbi.nlm.nih.gov\/31628959\/","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5512_CR38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ijrobp.2009.10.056","volume":"79","author":"M Mizumoto","year":"2011","unstructured":"Mizumoto M et al. (2011). Available: Radiotherapy for patients with metastases to the spinal column: a review of 603 patients at Shizuoka Cancer center Hospital. Int J Multiling Radiat Oncol*Biol*Phys 79(1):208\u2013213. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.10.056:https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0360301609035330","journal-title":"Int J Multiling Radiat Oncol*Biol*Phys"},{"issue":"2","key":"5512_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3171\/SPI-07\/08\/151","volume":"7","author":"EL Chang","year":"2007","unstructured":"Chang EL et al. (2007). Available: Phase I\/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 7(2):151\u2013160. https:\/\/doi.org\/10.3171\/SPI-07\/08\/151:https:\/\/thejns.org\/spine\/view\/journals\/j-neurosurg-spine\/7\/2\/article-p151.xml","journal-title":"J Neurosurg Spine"},{"key":"5512_CR40","doi-asserted-by":"crossref","unstructured":"Thibault I et al. (2013). Available: Local control, patterns of failure, and vertebral compression fracture after Spine stereotactic radiation therapy for metastatic Renal cell Cancer. Int J Radiat Oncol Biol Phys 87(2):S273\u2013S274. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.06.714:https:\/\/www.redjournal.org\/article\/S0360-3016(13)01384-9\/fulltext","DOI":"10.1016\/j.ijrobp.2013.06.714"},{"key":"5512_CR41","doi-asserted-by":"crossref","unstructured":"Sahgal A et al. (2007). Available: Proximity of Spinous\/Paraspinous radiosurgery metastatic targets to the spinal cord versus risk of local failure. Int J Radiat Oncol Biol Phys 69(3):S243. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.07.1240:https:\/\/www.redjournal.org\/article\/S0360-3016(07)02521-7\/fulltext","DOI":"10.1016\/j.ijrobp.2007.07.1240"},{"issue":"5","key":"5512_CR42","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.ijrobp.2008.06.1949","volume":"73","author":"JW Nelson","year":"2009","unstructured":"Nelson JW et al. (2009). Available: Stereotactic body radiotherapy for lesions of the Spine and paraspinal regions. Int J Multiling Radiat Oncol*Biol*Phys 73(5):1369\u20131375. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.06.1949:https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0360301608031027","journal-title":"Int J Multiling Radiat Oncol*Biol*Phys"},{"issue":"1","key":"5512_CR43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijrobp.2020.11.021","volume":"110","author":"SG Soltys","year":"2021","unstructured":"Soltys SG et al. (2021). Available: Stereotactic body radiation therapy for spinal metastases: tumor control probability analyses and Recommended reporting standards. Int J Multiling Radiat Oncol*Biol*Phys 110(1):112\u2013123. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.11.021:https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0360301620345430","journal-title":"Int J Multiling Radiat Oncol*Biol*Phys"},{"issue":"15","key":"5512_CR44","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1002\/cncr.25918","volume":"117","author":"AK Garg","year":"2011","unstructured":"Garg AK et al. (2011). Available: Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy: the University of Texas MD Anderson Cancer center experience. Cancer 117(15):3509\u20133516. https:\/\/doi.org\/10.1002\/cncr.25918:https:\/\/pubmed.ncbi.nlm.nih.gov\/21319143\/","journal-title":"Cancer"},{"issue":"4","key":"5512_CR45","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3171\/2017.2.SPINE16976","volume":"27","author":"S Myrehaug","year":"2017","unstructured":"Myrehaug S et al. (2017). Available: Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review. J Neurosurg Spine 27(4):428\u2013435. https:\/\/doi.org\/10.3171\/2017.2.SPINE16976:https:\/\/pubmed.ncbi.nlm.nih.gov\/28708043\/","journal-title":"J Neurosurg Spine"},{"key":"5512_CR46","doi-asserted-by":"publisher","first-page":"110940","DOI":"10.1016\/j.radonc.2025.110940","volume":"208","author":"M Guckenberger","year":"2025","unstructured":"Guckenberger M et al. (2025). Available: Dose-intensified SBRT for vertebral oligometastases: results from a prospective clinical trial. Radiother Oncol 208:110940. https:\/\/doi.org\/10.1016\/j.radonc.2025.110940:https:\/\/pubmed.ncbi.nlm.nih.gov\/40378895\/","journal-title":"Radiother Oncol"},{"issue":"2","key":"5512_CR47","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ijrobp.2006.09.025","volume":"67","author":"D Rades","year":"2007","unstructured":"Rades D et al. (2007). Available: Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression. Int J Multiling Radiat Oncol*Biol*Phys 67(2):525\u2013531. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.09.025:https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0360301606029944","journal-title":"Int J Multiling Radiat Oncol*Biol*Phys"},{"issue":"2","key":"5512_CR48","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/cncr.20756","volume":"103","author":"YM van der Linden","year":"2005","unstructured":"van der Linden YM et al. (2005). Available: Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 103(2):320\u2013328. https:\/\/doi.org\/10.1002\/cncr.20756:https:\/\/pubmed.ncbi.nlm.nih.gov\/15593360\/","journal-title":"Cancer"},{"key":"5512_CR49","unstructured":"Masashi Mizumoto MD et al. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression |. Journal of clinical oncology,\u201d Available: https:\/\/ascopubs.org\/doi\/full\/10.1200\/JCO.2005.05.0542"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05512-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05512-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05512-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:16:05Z","timestamp":1778224565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05512-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["5512"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05512-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8730558\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was retrospective in nature with no potential harm to those involved. Research took place under an approved IRB from Johns Hopkins University and did not require specific ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"KJR: research funding from Accuray, Canon, Icotec, GammaTile and Teleflex; honorarium for speaking engagement from Accuray and Icotec; travel support from Brainlab and Icotec; patent under development with Canon; Data Safety Monitoring Board for BioMimetix. DL: Consulting for Globus, Johnson and Johnson, Hemoblast, and research support from Icotec, AO foundation, Premier Inc. All other authors of no relevant funding or non-funding competing interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}